Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status.
Doenyas-Barak K, Berman S, Abu-Hamad R, Golik A, Rahimi-Levene N, Efrati S. Doenyas-Barak K, et al. Among authors: efrati s. Eur J Clin Pharmacol. 2012 Aug;68(8):1139-46. doi: 10.1007/s00228-012-1235-4. Epub 2012 Feb 25. Eur J Clin Pharmacol. 2012. PMID: 22367427 Clinical Trial.
ACE inhibitors and survival of hemodialysis patients.
Efrati S, Zaidenstein R, Dishy V, Beberashvili I, Sharist M, Averbukh Z, Golik A, Weissgarten J. Efrati S, et al. Am J Kidney Dis. 2002 Nov;40(5):1023-9. doi: 10.1053/ajkd.2002.36340. Am J Kidney Dis. 2002. PMID: 12407648
The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography.
Efrati S, Dishy V, Averbukh M, Blatt A, Krakover R, Weisgarten J, Morrow JD, Stein MC, Golik A. Efrati S, et al. Kidney Int. 2003 Dec;64(6):2182-7. doi: 10.1046/j.1523-1755.2003.00322.x. Kidney Int. 2003. PMID: 14633141 Clinical Trial.
The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis.
Dishy V, Cohen Pour M, Feldman L, Naftali T, Baumer M, Efrati S, Golik A, Horne T, Weissgarten J. Dishy V, et al. Among authors: efrati s. Clin Pharmacol Ther. 2004 Sep;76(3):281-6. doi: 10.1016/j.clpt.2004.04.012. Clin Pharmacol Ther. 2004. PMID: 15371988
Renal functional deterioration is not affected by the magnitude of sodium consumption in a normotensive model of moderate renal failure.
Weissgarten J, Berman S, Efrati S, Rapoport M, Aladjem M, Modai D, Golik A, Cohen N, Galperin E, Averbukh Z. Weissgarten J, et al. Among authors: efrati s. Am J Nephrol. 2005 Nov-Dec;25(6):541-7. doi: 10.1159/000088673. Epub 2005 Sep 30. Am J Nephrol. 2005. PMID: 16205053
Clonal variability of group B Streptococcus among different groups of carriers in southern Israel.
Marchaim D, Efrati S, Melamed R, Gortzak-Uzan L, Riesenberg K, Zaidenstein R, Schlaeffer F. Marchaim D, et al. Among authors: efrati s. Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):443-8. doi: 10.1007/s10096-006-0163-6. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16802129
Hyperbaric oxygen therapy for nonhealing vasculitic ulcers.
Efrati S, Bergan J, Fishlev G, Tishler M, Golik A, Gall N. Efrati S, et al. Clin Exp Dermatol. 2007 Jan;32(1):12-7. doi: 10.1111/j.1365-2230.2006.02240.x. Epub 2006 Jul 27. Clin Exp Dermatol. 2007. PMID: 16879451
Blockade of renin-angiotensin system reduces QT dispersion and improves intracellular Ca/Mg status in hemodialysis patients.
Averbukh Z, Berman S, Efrati S, Manevits E, Rosenberg R, Malcev E, Galperin E, Weissgarten J. Averbukh Z, et al. Among authors: efrati s. Nephron Clin Pract. 2006;104(4):c176-84. doi: 10.1159/000095853. Epub 2006 Sep 22. Nephron Clin Pract. 2006. PMID: 17003569 Clinical Trial.
The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.
Efrati S, Averbukh M, Dishy V, Faygenzo M, Friedensohn L, Golik A. Efrati S, et al. Eur J Clin Pharmacol. 2007 Feb;63(2):113-21. doi: 10.1007/s00228-006-0238-4. Epub 2007 Jan 3. Eur J Clin Pharmacol. 2007. PMID: 17200833 Clinical Trial.
N-acetylcysteine attenuates NSAID-induced rat renal failure by restoring intrarenal prostaglandin synthesis.
Efrati S, Berman S, Siman-Tov Y, Lotan R, Averbukh Z, Weissgarten J, Golik A. Efrati S, et al. Nephrol Dial Transplant. 2007 Jul;22(7):1873-81. doi: 10.1093/ndt/gfm113. Epub 2007 Mar 29. Nephrol Dial Transplant. 2007. PMID: 17400565
152 results
Jump to page